| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/15/2006 | US7091237 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/15/2006 | US7091236 Method for increasing the bioavailability of glycopyrrolate |
| 08/15/2006 | US7091235 substituted with p-chlorobenzene and a pyrrolethoxybenzene; antitumor |
| 08/15/2006 | US7091234 Thio-oxindole derivatives |
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091231 (Z)-7-{(1R,2S,3R)-2-[4-(Cyclohexyl-hydroxy-methyl)-phenyl]-3-hydroxy-5-oxo-cyclopentyl}-hept-5-enoic acid methyl ester compounds and isomers; EP2 selective agonists; treating glaucoma |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091229 1,1-Dioxo-2H-naphtho(1,8-cd)isothiazole or 2-oxo-2H-benzo(cd)indole derivatives as anticarcinogenic or antiproliferative agents |
| 08/15/2006 | US7091228 4-[4'-(1,3-Benzothiazol-2-ylamino)-1,1'-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acid and derivatives; inhibition of DGAT-1 (diacylglycerol O-acyltransferase type 1) |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091226 Cancer treatment with epothilones |
| 08/15/2006 | US7091225 Substituted oxazoles and thiazoles as hPPAR alpha agonists |
| 08/15/2006 | US7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091222 4-(1,2-Dimethyl-1H-imidazol-4-ylethynyl)-2-methyl-pyridine compounds; treating chronic neurological disorders |
| 08/15/2006 | US7091221 Partial ester of cellulose with nitrogenous carboxylic acid and process for producing the same |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/15/2006 | US7091218 4-indenone, n-benzyl substituted piperdine compounds; inhibiting acetylcholinesterase to treat Alzheimer-type senile dementia |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091216 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
| 08/15/2006 | US7091215 Corticotropin-Releasing Factor (CRF) receptor antagonist |
| 08/15/2006 | US7091214 Immonomoderators; viricides; anticancer agents |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091212 Chiral dinapsoline |
| 08/15/2006 | US7091211 3-(aryl or heteroaryl)-4-((spiropiperidin-1-yl)alkyl)cyclopentyl compounds and stereisomers, used for prevention of lymphadenopathy associated virus infection, and delaying the onset of aquired immune deficiency syndrome |
| 08/15/2006 | US7091210 Substituted 2-aminoacetamides and the use thereof |
| 08/15/2006 | US7091209 Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091207 Method of treating myocardial infarction with PDE-5 inhibitors |
| 08/15/2006 | US7091205 Use of tetramethylpyrazine in the treatment of brain tumor |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091203 Imidazo[1,3,5]triazinones and their use |
| 08/15/2006 | US7091202 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators |
| 08/15/2006 | US7091201 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 08/15/2006 | US7091199 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
| 08/15/2006 | US7091198 2,5-disubstituted pyrimidine derivatives |
| 08/15/2006 | US7091197 Beta-lactamase inhibitor prodrug |
| 08/15/2006 | US7091196 triazoles and optionally carrier mixtures used for prohylaxis of infections, as antiproliferative agents, fungicides, bactericides, parasiticides, viricides, antiinflammatory agents and/or prokinetic agents (gastrointestinal modulatory) |
| 08/15/2006 | US7091195 Derived from plants; for preventing or inhibiting tumor growth |
| 08/15/2006 | US7091194 Method for increasing the production of propionate in the gastrointestinal tract |
| 08/15/2006 | US7091193 A freeze drying mixture comprising an epothilone and a cyclodextrin; antiproliferative agent, anticarcinogenic agent; cancer, psoriasis, restenosis, multiple sclerosis, rheumatoid arthritis, atherosclerosis; side effect reduction |
| 08/15/2006 | US7091192 Linear cyclodextrin copolymers |
| 08/15/2006 | US7091191 Modified hyaluronic acid for use in musculoskeletal tissue repair |
| 08/15/2006 | US7091190 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/15/2006 | US7091189 Medicament for treating lung cancer |
| 08/15/2006 | US7091187 Using steroid; autoimmune disease |
| 08/15/2006 | US7091182 Analyzing a blood sample for secretin level |
| 08/15/2006 | US7091040 P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT) |
| 08/15/2006 | US7091030 Composition for the preservation of viruses |
| 08/15/2006 | US7090986 identifying compounds such as antibodies that compete with the binding of Saratin to collagen by determining the binding of said Saratin to collagen in the presence or absence of a competitor. |
| 08/15/2006 | US7090887 Oilseed processing |
| 08/15/2006 | US7090875 Bean extract; fermentation |
| 08/15/2006 | US7090874 comprises curcumin for preventing and/or improving Insulin Resistance Syndrome, diabetes mellitus, obesity or visceral fat obesity, hypertension or arterosclerotic cardiovascular disorders |
| 08/15/2006 | US7090872 comprises acerola seed extract containing quercitrin |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/15/2006 | US7090869 Suppressing the instant release or denaturation of active material, by mixing with a biodegradable polymer, solidification with high-pressure gas; drug delivery, sustained releasing growth hormone, candesartan |
| 08/15/2006 | US7090866 Opioid agonist in a fast dispersing dosage form |
| 08/15/2006 | US7090865 Preventing antibody-induced anemia by administering a complexes of bisphosphonate |
| 08/15/2006 | US7090864 Non-invasive gene targeting to ocular cells |
| 08/15/2006 | US7090863 Hypocholesterolemic composition and methods of use |
| 08/15/2006 | US7090862 Administering natural tocopherols including alpha- and gamma-forms; also prenatal supplements and supplements for lactating women |
| 08/15/2006 | US7090861 Sustained release delivery systems for solutes |
| 08/15/2006 | US7090858 Coated filter bag material for oral administration of medicament in liquid and methods of making same |
| 08/15/2006 | US7090857 Polysaccharides and/or glycopeptides preparable from keratinophilic fungi and yeasts; vaccines, immunomodulators, and antiallergens; precipitation and separation of supernatant; treatment with mineral or organic acid |
| 08/15/2006 | US7090856 Anti-fouling exopolysaccharides isolated from cultures of Vibrio alginolyticus and Vibrio proteolyticus |
| 08/15/2006 | US7090853 Noscapine derivatives as adjuvant compositions and methods of use thereof |
| 08/15/2006 | US7090846 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 08/15/2006 | US7090836 Vector for expressing α-L-iduronidase and method of treating MPS I by stereotactic injection into the brain of a mammal |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | US7090832 Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same |
| 08/15/2006 | US7090831 Pharmaceutical aerosol formulation |
| 08/15/2006 | US7090691 Photodynamic therapy for the treatment of hair loss |
| 08/15/2006 | CA2395231C Hydrogel-driven layered drug dosage form |
| 08/15/2006 | CA2287267C Improved methods for processing activated protein c |
| 08/15/2006 | CA2285535C Benzimidazole derivative for treating allergy-related disease |
| 08/15/2006 | CA2274135C Novel therapeutic application of a thienycyclohexylamine derivative |
| 08/15/2006 | CA2270558C Treatment of autoimmune diseases by photochemotherapy |
| 08/15/2006 | CA2258752C Naphthyridines which affect il-4 and g-csf |
| 08/15/2006 | CA2256309C Amidino protease inhibitors |
| 08/15/2006 | CA2255070C Novel compounds having antiviral activity |
| 08/15/2006 | CA2238871C Method of using beta-interferons to treat restenosis |
| 08/15/2006 | CA2238376C Benzofuran carboxamides and sulphonamides |
| 08/15/2006 | CA2236896C 1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation |
| 08/15/2006 | CA2230808C A novel purine derivative |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/15/2006 | CA2213987C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
| 08/15/2006 | CA2211612C [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides |
| 08/15/2006 | CA2211325C Extended release clonidine formulation |
| 08/15/2006 | CA2200126C Treatment and prophylaxis of pancreatitis |
| 08/15/2006 | CA2190983C New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 08/15/2006 | CA2168193C Aryalkyl-thiadiazinones |
| 08/15/2006 | CA2164776C Pharmaceutical, orally applicable composition |
| 08/15/2006 | CA2161783C Ampa antagonists and a method of treatment therewith |
| 08/15/2006 | CA2155329C Acylfulvene analogues as antitumor agents |
| 08/15/2006 | CA2150805C Antiallergic imidazo[1,2-a](pyrrolo, thieno or furano)[2,3-d]azepine derivatives |
| 08/15/2006 | CA2107439C Phospholipid derivatives containing phosphorous, arsenic, antimony or bismuth |
| 08/10/2006 | WO2006084281A1 Inhibitors of e1 activating enzymes |
| 08/10/2006 | WO2006084265A1 11a, 12-DERIVATIVES OF TETRACYCLINE COMPOUNDS |